Skip to main content
JAMA Network logoLink to JAMA Network
. 2018 Apr 12;4(4):590. doi: 10.1001/jamaoncol.2018.1047

Errors in Author Affiliations

PMCID: PMC8177296  PMID: 29677377

In the article titled “Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial,”1 2 incorrect author affiliations have been corrected. The correct affiliation for Dr Verweij is “Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands,” and the correct affiliation for Dr Gronchi is “Department of Surgery, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy.” The article was corrected online. This article was also corrected on March 8, 2018, for a typographical error in the label for panel C in Figure 2.

Reference

  • 1.Issels RD, Lindner LH, Verweij J, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial [published online February 15, 2018]. JAMA Oncol. doi: 10.1001/jamaoncol.2017.4996 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES